Le Lézard
Classified in: Health
Subject: SVY

FDAnews Announces -- The GMP Letter Newsletter Subscription

FALLS CHURCH, Va., March 27, 2020 /PRNewswire-PRWeb/ -- The GMP Letter
An FDAnews Newsletter

Inspections... quality regulations... guidances... recalls... CAPA... MDR reporting... cybersecurity... UDI...

What is it like to have access to the inner workings of the FDA or a trusted friend there to share insights into the interpretation and enforcement of cGMPs and quality systems regulation (QSR)?

The GMP Letter is the go-to resource. This newsletter has the insights and latest news one can rely on to ensure the processes, procedures and controls are compliant.

Each month, The GMP Letter's executive briefings bring subscribers the latest on:

?FDA's approach to facility inspections such as the agency's increasing focus on data security
?Changes to the EU's inspections for MDR compliance
?Joint recognition of GMP inspections in the U.S., EU and other jurisdictions
?Quality regulations and guidances for instance on cybersecurity and data integrity

For the past 30 years, devicemakers who have relied on The GMP Letter have had much-needed information and analysis, enabling them to act swiftly to adjust manufacturing processes.

Bonus! Subscribers also receive critical documents including 483s, warning letters, closeout letters, FDA policy notices and more.

Start a one-year subscription (12 issues) to The GMP Letter for only $1,085. Take advantage of our 100% Money-Back Guarantee. We're confident the value GMP provides will pay for itself many times over.

Newsletter Details:
Drug GMP Report
An FDAnews Newsletter


Easy Ways to Register:
Online: https://www.fdanews.com/subscribe-now/drug-gmp-report
By phone: 888.838.5578 or 703.538.7600

About FDAnews:
FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on FDAnews' print and electronic newsletters, books and conferences to stay in compliance with international standards and the FDA's complex and ever-changing regulations



These press releases may also interest you

at 10:13
The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the VOYAGER PAD study met its primary efficacy and principal safety endpoints, demonstrating the XARELTO® (rivaroxaban) vascular dose (2.5 mg twice daily) plus aspirin (100 mg...

at 10:05
Merck , known as MSD outside the United States and Canada, today announced the presentation of results from the VICTORIA trial, a Phase 3 study evaluating the efficacy and safety of its investigational drug vericiguat, an orally administered soluble...

at 10:00
Amgen today announced positive results from the EvolocumaB Effect on LDL-C LowerIng in SubJEcts with Human Immunodeficiency ViRus and INcreased Cardiovascular RisK (BEIJERINCK) study evaluating the efficacy and safety of Repatha® (evolocumab) in...

at 10:00
Edwards Lifesciences Corporation , the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced it will temporarily pause new enrollments in its active pivotal clinical trials of...

at 10:00
Ryvu Therapeutics (WSE: RVU), a clinical-stage biopharmaceutical company developing novel small molecule therapies that address emerging targets in oncology, today announced that the U.S. Food and Drug Administration (FDA) has granted an orphan drug...

at 10:00
MediStreams, a growing leader in the HRCM market offers an end-to-end payment processing solution. The MediStreams' proprietary and innovative platform integrates into the provider's A/R workflow. It ingests all payments; both commercial and patient...

News published on 27 march 2020 at 02:00 and distributed by: